Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry

Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug S... Ver más

Guardado en:

2256-2877

2256-2915

8

2022-09-21

211

212

http://purl.org/coar/access_right/c_abf2

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Carlos Andrés Ossa Gomez - 2022

info:eu-repo/semantics/openAccess

id 4c32ec6e52c12bc78f5dac61a5bf10c7
record_format ojs
spelling Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
Echeverri, Carolina
Asociación Colombiana de Hematología y Oncología (ACHO)
Artículo de revista
Suplemento 1
8
Lymphoma
Breast
Implants
BIA-ALCL
Breast lymphoma
Revista Colombiana de Hematología y Oncología
Abello Polo, Virginia
Rivas Taffur, Giovanna
Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug Surveillance Institute) to track national cases of BIA-ALCL. Materials and Methods: We performed a retrospective review (survey-based study) of historical cases since 2011–2019, and a prospective collection of all patients with a confirmed World Health Organization diagnosis of BIA-ALCL identified in a newly established National Registry of BIA-ALCL. The trial was approved by Institutional Review Board (IRB).
Ossa Gomez, Carlos Andrés
Duque, Alejandro
Fidalgo, Ana Maria
Huertas Motta, Ramiro
Caicedo Mallarino, José Joaquín
Mantilla Duran, William Armando
http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/access_right/c_abf2
https://revista.acho.info/index.php/acho/article/view/489
http://purl.org/coar/version/c_970fb48d4fbd8a85
Text
info:eu-repo/semantics/article
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Carlos Andrés Ossa Gomez - 2022
https://creativecommons.org/licenses/by-nc-sa/4.0
Inglés
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/publishedVersion
Journal article
Publication
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug Surveillance Institute) to track national cases of BIA-ALCL. Materials and Methods: We performed a retrospective review (survey-based study) of historical cases since 2011–2019, and a prospective collection of all patients with a confirmed World Health Organization diagnosis of BIA-ALCL identified in a newly established National Registry of BIA-ALCL. The trial was approved by Institutional Review Board (IRB).
Breast lymphoma
application/pdf
BIA-ALCL
Implants
Breast
Lymphoma
2256-2915
https://revista.acho.info/index.php/acho/article/download/489/463
2256-2877
211
2022-09-21T00:00:00Z
2022-09-21T00:00:00Z
2022-09-21
https://doi.org/10.51643/22562915.489
10.51643/22562915.489
212
institution ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA
thumbnail https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png
country_str Colombia
collection Revista Colombiana de Hematología y Oncología
title Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
spellingShingle Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
Echeverri, Carolina
Abello Polo, Virginia
Rivas Taffur, Giovanna
Ossa Gomez, Carlos Andrés
Duque, Alejandro
Fidalgo, Ana Maria
Huertas Motta, Ramiro
Caicedo Mallarino, José Joaquín
Mantilla Duran, William Armando
Lymphoma
Breast
Implants
BIA-ALCL
Breast lymphoma
Breast lymphoma
BIA-ALCL
Implants
Breast
Lymphoma
title_short Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
title_full Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
title_fullStr Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
title_full_unstemmed Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
title_sort breast implant–associated anaplastic large cell lymphoma in colombia: report of a multidisciplinary national registry
title_eng Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
description Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug Surveillance Institute) to track national cases of BIA-ALCL. Materials and Methods: We performed a retrospective review (survey-based study) of historical cases since 2011–2019, and a prospective collection of all patients with a confirmed World Health Organization diagnosis of BIA-ALCL identified in a newly established National Registry of BIA-ALCL. The trial was approved by Institutional Review Board (IRB).
description_eng Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug Surveillance Institute) to track national cases of BIA-ALCL. Materials and Methods: We performed a retrospective review (survey-based study) of historical cases since 2011–2019, and a prospective collection of all patients with a confirmed World Health Organization diagnosis of BIA-ALCL identified in a newly established National Registry of BIA-ALCL. The trial was approved by Institutional Review Board (IRB).
author Echeverri, Carolina
Abello Polo, Virginia
Rivas Taffur, Giovanna
Ossa Gomez, Carlos Andrés
Duque, Alejandro
Fidalgo, Ana Maria
Huertas Motta, Ramiro
Caicedo Mallarino, José Joaquín
Mantilla Duran, William Armando
author_facet Echeverri, Carolina
Abello Polo, Virginia
Rivas Taffur, Giovanna
Ossa Gomez, Carlos Andrés
Duque, Alejandro
Fidalgo, Ana Maria
Huertas Motta, Ramiro
Caicedo Mallarino, José Joaquín
Mantilla Duran, William Armando
topicspa_str_mv Lymphoma
Breast
Implants
BIA-ALCL
Breast lymphoma
topic Lymphoma
Breast
Implants
BIA-ALCL
Breast lymphoma
Breast lymphoma
BIA-ALCL
Implants
Breast
Lymphoma
topic_facet Lymphoma
Breast
Implants
BIA-ALCL
Breast lymphoma
Breast lymphoma
BIA-ALCL
Implants
Breast
Lymphoma
citationvolume 8
citationissue Suplemento 1
publisher Asociación Colombiana de Hematología y Oncología (ACHO)
ispartofjournal Revista Colombiana de Hematología y Oncología
source https://revista.acho.info/index.php/acho/article/view/489
language Inglés
format Article
rights http://purl.org/coar/access_right/c_abf2
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Carlos Andrés Ossa Gomez - 2022
https://creativecommons.org/licenses/by-nc-sa/4.0
info:eu-repo/semantics/openAccess
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2022-09-21
date_accessioned 2022-09-21T00:00:00Z
date_available 2022-09-21T00:00:00Z
url https://revista.acho.info/index.php/acho/article/view/489
url_doi https://doi.org/10.51643/22562915.489
issn 2256-2877
eissn 2256-2915
doi 10.51643/22562915.489
citationstartpage 211
citationendpage 212
url2_str_mv https://revista.acho.info/index.php/acho/article/download/489/463
_version_ 1797159833383731200